Exclusive

Publication

Byline

Location

US Patent Issued to VICORE PHARMA on Aug. 25 for "Process for the synthesis of N-butyloxycarbonyl-3-(4-imidazol-1-ylmethylphenyl)-5-iso-butylthiophene-2-sulfonamide" (Latvian Inventors)

ALEXANDRIA, Va., Aug. 25 -- United States Patent no. 12,715,864, issued on Aug. 25, was assigned to VICORE PHARMA AB (Stockholm). "Process for the synthesis of N-butyloxycarbonyl-3-(4-imidazol-1-ylme... Read More


US Patent Issued to EVOTEC INTERNATIONAL on Aug. 25 for "Modulators of the integrated stress response pathway" (British, American Inventors)

ALEXANDRIA, Va., Aug. 25 -- United States Patent no. 12,715,865, issued on Aug. 25, was assigned to EVOTEC INTERNATIONAL GMBH (Hamburg, Germany). "Modulators of the integrated stress response pathway... Read More


US Patent Issued to SK BIOPHARMACEUTICALS on Aug. 25 for "Bicyclic compound and use thereof" (South Korean Inventors)

ALEXANDRIA, Va., Aug. 25 -- United States Patent no. 12,715,866, issued on Aug. 25, was assigned to SK BIOPHARMACEUTICALS Co. LTD. (Gyeonggi-do, South Korea). "Bicyclic compound and use thereof" was ... Read More


US Patent Issued to HALO Therapeutics on Aug. 25 for "Agonists of free fatty acid receptor 1 and their use in diseases associated with said receptor" (Ukrainian, Swiss Inventors)

ALEXANDRIA, Va., Aug. 25 -- United States Patent no. 12,715,867, issued on Aug. 25, was assigned to HALO Therapeutics Ltd (Caerphilly, Great Britain). "Agonists of free fatty acid receptor 1 and thei... Read More


US Patent Issued to Amgen on Aug. 25 for "SMARCA2-VHL degraders" (American, Indian Inventors)

ALEXANDRIA, Va., Aug. 25 -- United States Patent no. 12,715,868, issued on Aug. 25, was assigned to Amgen Inc. (Thousand Oaks, Calif.). "SMARCA2-VHL degraders" was invented by Abhisek Banerjee (Banga... Read More


US Patent Issued to Celgene on Aug. 25 for "Modulators of CAMKK2 as ligand directed degraders" (California, Massachusetts Inventors)

ALEXANDRIA, Va., Aug. 25 -- United States Patent no. 12,715,869, issued on Aug. 25, was assigned to Celgene Corp. (Princeton, N.J.). "Modulators of CAMKK2 as ligand directed degraders" was invented b... Read More


US Patent Issued to Beijing Innocare Pharma Tech on Aug. 25 for "Heterocyclic compound as BCL-2 inhibitor" (Chinese Inventors)

ALEXANDRIA, Va., Aug. 25 -- United States Patent no. 12,715,870, issued on Aug. 25, was assigned to Beijing Innocare Pharma Tech Co. Ltd. (Beijing). "Heterocyclic compound as BCL-2 inhibitor" was inv... Read More


US Patent Issued to SHANGHAI RINGENE BIOPHARMA on Aug. 25 for "Aromatic ring-lactam compound, preparation method therefor and use thereof" (Chinese Inventors)

ALEXANDRIA, Va., Aug. 25 -- United States Patent no. 12,715,871, issued on Aug. 25, was assigned to SHANGHAI RINGENE BIOPHARMA Co. LTD. (Shanghai). "Aromatic ring-lactam compound, preparation method ... Read More


US Patent Issued to Cambridge Enterprise on Aug. 25 for "Benzo[c[2,6naphthyridine derivatives, compositions and therapeutic uses thereof" (British Inventors)

ALEXANDRIA, Va., Aug. 25 -- United States Patent no. 12,715,872, issued on Aug. 25, was assigned to Cambridge Enterprise Ltd. (Cambridge, Great Britain). "Benzo[c[2,6naphthyridine derivatives, compos... Read More


US Patent Issued to BroadenBio on Aug. 25 for "Pyrazolopyridazinone compound, and pharmaceutical composition and use thereof" (Chinese Inventors)

ALEXANDRIA, Va., Aug. 25 -- United States Patent no. 12,715,873, issued on Aug. 25, was assigned to BroadenBio Co. Ltd. (Beijing). "Pyrazolopyridazinone compound, and pharmaceutical composition and u... Read More